Published in Bone on March 31, 2010
Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite. Calcif Tissue Int (2013) 0.96
Mineral and matrix changes in Brtl/+ teeth provide insights into mineralization mechanisms. Biomed Res Int (2013) 0.81
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development (2004) 2.54
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
DSPP mutation in dentinogenesis imperfecta Shields type II. Nat Genet (2001) 2.39
Hereditary dentin defects. J Dent Res (2007) 2.33
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem (2004) 2.25
Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood (2006) 2.02
Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int (2002) 1.91
Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol Cell Biol (2006) 1.86
Genetic variation in bone growth patterns defines adult mouse bone fragility. J Bone Miner Res (2005) 1.66
The contribution of the organic matrix to bone's material properties. Bone (2002) 1.64
Contribution of collagen and mineral to the elastic-plastic properties of bone. J Bone Joint Surg Am (1975) 1.55
Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res (2001) 1.55
Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells (2006) 1.46
PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol (2008) 1.41
Molecular basis of human dentin diseases. Am J Med Genet A (2006) 1.24
DSPP effects on in vivo bone mineralization. Bone (2008) 1.19
A scanning electron microscopic study of hypercementosis. J Appl Oral Sci (2008) 1.15
Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev Dyn (2007) 1.15
RPL29 codes for a non-essential protein of the 60S ribosomal subunit in Saccharomyces cerevisiae and exhibits synthetic lethality with mutations in genes for proteins required for subunit coupling. Biochim Biophys Acta (2002) 1.09
Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect Tissue Res (1996) 1.08
Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol (2008) 1.06
Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone (2001) 1.04
Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone. Calcif Tissue Int (2007) 1.02
Variation in mineral properties in normal and mutant bones and teeth. Cells Tissues Organs (2005) 0.98
Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone (2009) 0.97
Osteogenesis imperfecta. J Am Acad Orthop Surg (1998) 0.96
Assessment of bone mineral and matrix using backscatter electron imaging and FTIR imaging. Curr Osteoporos Rep (2006) 0.95
Ribosomal protein mutations in Diamond-Blackfan anemia: might they operate upstream from protein synthesis? FASEB J (2007) 0.93
Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J Orthop Res (2009) 0.91
HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation (2003) 0.89
Dynamics of recovery of morphometrical variables and pQCT-derived cortical bone properties after a short-term protein restriction in maturing rats. Growth Dev Aging (2002) 0.81
Increased Young's modulus and hardness of Col1a2oim dentin. J Dent Res (2006) 0.80
Structural and composition studies on the mineral of newly formed dental enamel: a chemical, x-ray diffraction, and 31P and proton nuclear magnetic resonance study. J Bone Miner Res (1991) 0.77
A promoter-level mammalian expression atlas. Nature (2014) 6.25
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem (2004) 2.25
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res (2012) 2.05
Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood (2010) 1.98
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
Retracted Tunable plasmonic nanoprobes for theranostics of prostate cancer. Theranostics (2011) 1.73
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell (2009) 1.72
Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod (2002) 1.71
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res (2008) 1.64
Infrared assessment of bone quality: a review. Clin Orthop Relat Res (2011) 1.63
Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am (2005) 1.61
Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment. Bone (2012) 1.60
beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res (2006) 1.55
Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res (2009) 1.54
Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res (2009) 1.52
Limited availability of ZBP1 restricts axonal mRNA localization and nerve regeneration capacity. EMBO J (2011) 1.49
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone (2009) 1.47
Effects of surface roughness and maximum load on the mechanical properties of cancellous bone measured by nanoindentation. J Biomed Mater Res A (2006) 1.46
Effects of tissue age on bone tissue material composition and nanomechanical properties in the rat cortex. J Biomed Mater Res A (2010) 1.45
RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res (2005) 1.38
Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A (2010) 1.38
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate (2007) 1.37
Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials (2009) 1.37
Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res (2006) 1.34
β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res (2011) 1.33
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A (2010) 1.33
T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab (2009) 1.32
Dilatational band formation in bone. Proc Natl Acad Sci U S A (2012) 1.32
Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. J Biol Chem (2007) 1.32
Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc (2005) 1.31
Mineral changes in osteoporosis: a review. Clin Orthop Relat Res (2006) 1.31
Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int (2010) 1.30
Axonal Localization of transgene mRNA in mature PNS and CNS neurons. J Neurosci (2011) 1.28
Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem (2005) 1.27
A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem (2007) 1.25
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A (2013) 1.23
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum (2006) 1.23
Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci (2009) 1.22
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
DSPP effects on in vivo bone mineralization. Bone (2008) 1.19
Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer (2007) 1.19
The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials (2010) 1.18
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res (2002) 1.17
Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone (2007) 1.17
Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials (2005) 1.17
Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol (2010) 1.17
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13
Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials (2004) 1.13
LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One (2011) 1.12
Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks. Soft Matter (2012) 1.12
NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone (2009) 1.11
Evaluation of cross-linking methods for electrospun gelatin on cell growth and viability. Biomacromolecules (2009) 1.10
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res (2002) 1.09
Bone quality: from bench to bedside: opening editorial comment. Clin Orthop Relat Res (2011) 1.09
Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem (2003) 1.08
Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition. Calcif Tissue Int (2008) 1.08
Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol (2008) 1.06
Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng (2006) 1.06
Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials (2009) 1.05
Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clin Exp Metastasis (2005) 1.05
RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. J Bone Miner Res (2004) 1.04
Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res (2002) 1.03
Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. J Bone Miner Res (2011) 1.03
Microstructure and nanomechanical properties in osteons relate to tissue and animal age. J Biomech (2010) 1.03
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J Cell Biochem (2008) 1.02
Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem (2011) 1.02
Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res (2003) 1.02
Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. J Biol Chem (2007) 1.01
Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate (2009) 1.01
Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkappaB in differentiating NB4 leukemia cells. Exp Cell Res (2010) 1.00
Quantitative modeling and analysis of the transforming growth factor beta signaling pathway. Biophys J (2009) 1.00
Spectroscopically determined collagen Pyr/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinant congenic mice with divergent calculated bone tissue strength. Connect Tissue Res (2003) 1.00
Fiber diameters control osteoblastic cell migration and differentiation in electrospun gelatin. J Biomed Mater Res A (2010) 1.00
Hierarchically structured, hyaluronic acid-based hydrogel matrices via the covalent integration of microgels into macroscopic networks. Soft Matter (2010) 0.99
Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls. J Bone Miner Res (2013) 0.99
Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res (2011) 0.98
Decorin modulates collagen matrix assembly and mineralization. Matrix Biol (2008) 0.98
Variation in mineral properties in normal and mutant bones and teeth. Cells Tissues Organs (2005) 0.98
Lumen formation in three-dimensional cultures of salivary acinar cells. Otolaryngol Head Neck Surg (2010) 0.98
Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res (2003) 0.97
Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells. Clin Cancer Res (2011) 0.97
Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. Biomaterials (2010) 0.96
Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials (2012) 0.96
Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules (2007) 0.95
alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression. Lab Invest (2007) 0.95
Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochem Biophys Res Commun (2010) 0.95
Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crest. J Orthop Res (2011) 0.95
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLoS One (2012) 0.94